This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
News & Press: COVID-19

ABN guidance on COVID-19 for neurology patients

19 March 2020  
Share |

We appreciate the anxiety that the current COVID-19 outbreak has generated for patients with neurological conditions their families and carers. There is need for clear and definitive advice on which patient should be self-isolating and whether certain medications should be discontinued. This is a rapidly developing picture. National guidance on the use of immunological treatments is actively being developed through the Royal College of Physicians, to which specialist societies including the ABN will contribute. The consensus guidance will be developed with the Chief Medical Officer, with the expectation that this guidance will be published at the start of next week. Pending definitive guidance, we suggest that stable patients continue their treatment. Patients with symptoms of possible COVID-19 should follow national guidance by not visiting their GP or hospital, but contacting NHS 111.


Contact Us

Association of British Neurologists
Ormond House
27 Boswell Street
London
WC1N 3JZ

Telephone: +44 (0)20 7405 4060
Email: info@abn.org.uk

Registered Charity No. 1077893
Company No. 3816842

Follow Us